Prostigmin Bromide Interactions
There are 109 drugs known to interact with Prostigmin Bromide (neostigmine), along with 9 disease interactions. Of the total drug interactions, 8 are major, 100 are moderate, and 1 is minor.
- View all 109 medications that may interact with Prostigmin Bromide
- View Prostigmin Bromide disease interactions (9)
Most frequently checked interactions
View interaction reports for Prostigmin Bromide (neostigmine) and the medicines listed below.
- albuterol
- albuterol / ipratropium
- amitriptyline
- benzonatate
- citalopram
- copper sulfate
- Diltiazem Hydrochloride CD (diltiazem)
- DuoNeb (albuterol / ipratropium)
- Flexeril (cyclobenzaprine)
- hydrocodone
- Ipratropium Inhalation Aerosol (ipratropium)
- Keppra (levetiracetam)
- Levaquin (levofloxacin)
- Lipitor (atorvastatin)
- lovastatin
- Morphine Sulfate ER (morphine)
- Nexium (esomeprazole)
- nitroglycerin
- omeprazole
- oxycodone
- OxyContin (oxycodone)
- papaya
- Percocet (acetaminophen / oxycodone)
- prasugrel
- prednisone
- Protonix (pantoprazole)
- ranitidine
- temazepam
Prostigmin Bromide disease interactions
There are 9 disease interactions with Prostigmin Bromide (neostigmine) which include:
- bradycardia
- bronchospasm
- coronary artery disease
- parkinsonism
- PUD
- seizures
- intestinal/urinary obstruction
- hyperthyroidism
- hepatic impairment
More about Prostigmin Bromide (neostigmine)
- Prostigmin Bromide consumer information
- Compare alternatives
- Reviews (1)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: cholinergic muscle stimulants
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.